These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33608345)

  • 21. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia.
    Kabra NS; Patil VS; Dhanuka DG
    Indian J Ophthalmol; 2021 Dec; 69(12):3776-3777. PubMed ID: 34827049
    [No Abstract]   [Full Text] [Related]  

  • 23. Amniotic Membrane Grafting for Ocular Surface Inflammation Following Topical Interferon Alpha 2b Therapy.
    Shah SG; Mishra DK; Shah GY
    J Interferon Cytokine Res; 2022 Mar; 42(3):137-139. PubMed ID: 35298286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configuration.
    Shields CL; Constantinescu AB; Paulose SA; Yaghy A; Dalvin LA; Shields JA; Lally SE
    Indian J Ophthalmol; 2021 Mar; 69(3):563-567. PubMed ID: 33595473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.
    Kaliki S; Singh S; Iram S; Tripuraneni D
    Indian J Ophthalmol; 2016 Oct; 64(10):702-709. PubMed ID: 27905329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of conjunctival papilloma with topical interferon alpha-2b - case report.
    Bolek B; Wylęgała A; Teper S; Kokot J; Wylęgała E
    Medicine (Baltimore); 2020 Feb; 99(7):e19181. PubMed ID: 32049852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b.
    Rocha-de-Lossada C; Alba-Linero C; Borroni D; Rachwani-Anil R; Zamorano-Martín F; Rodríguez-Calvo-de-Mora M
    Rom J Ophthalmol; 2020; 64(1):62-65. PubMed ID: 32292860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE
    Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Topical interferon alfa-2b or surgical excision for primary treatment of conjunctiva-cornea intraepithelial neoplasia].
    Huerva V
    Arch Soc Esp Oftalmol; 2009 Jan; 84(1):5-6. PubMed ID: 19173133
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular surface squamous neoplasia: evidence for topical chemotherapy.
    Pe'er J
    Int Ophthalmol Clin; 2015; 55(1):9-21. PubMed ID: 25436490
    [No Abstract]   [Full Text] [Related]  

  • 32. Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease.
    Zhang L; Mercado C; Galor A; Holland EJ; Wang G; Karp CL
    Ocul Immunol Inflamm; 2019; 27(2):288-293. PubMed ID: 29190165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreduction of locally advanced orbito-conjunctival squamous cell carcinoma with intraorbital interferon alpha-2b injection: a globe saving approach.
    Meel R; Dhiman R; Sen S; Sharma S
    Clin Exp Ophthalmol; 2018 Jan; 46(1):87-88. PubMed ID: 28570760
    [No Abstract]   [Full Text] [Related]  

  • 34. Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia.
    Polski A; Sibug Saber M; Kim JW; Berry JL
    Clin Exp Ophthalmol; 2019 Mar; 47(2):193-200. PubMed ID: 30156057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b.
    Kobayashi A; Yoshita T; Uchiyama K; Shirao Y; Kitagawa K; Fujisawa A; Tseng SC
    Jpn J Ophthalmol; 2002; 46(2):215-7. PubMed ID: 12062230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.
    Huerva V; Mangues I
    J Fr Ophtalmol; 2008 Mar; 31(3):317-25. PubMed ID: 18404128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.